Expanding the paradigm of eosinophilic esophagitis: Mast cells and IL-9 - 30/05/13
Doi : 10.1016/j.jaci.2013.04.010
Yui-Hsi Wang, PhD ⁎ 
, Simon P. Hogan, PhD, Patricia C. Fulkerson, MD, PhD, J. Pablo Abonia, MD, Marc E. Rothenberg, MD, PhD
, Simon P. Hogan, PhD, Patricia C. Fulkerson, MD, PhD, J. Pablo Abonia, MD, Marc E. Rothenberg, MD, PhD Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
∗Corresponding author: Yui-Hsi Wang, PhD, Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, MCL 7028, 3333 Burnet Ave, Cincinnati, OH 45229-3039.
Key words : Eosinophilic esophagitis, immunology, mast cells, IL-9
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: Y.-H. Wang has received grants from the National Institutes of Health (NIH). S. P. Hogan has received grants from the NIH and has consultant arrangements with Immune Pharmaceuticals. J. P. Abonia has received grants from the NIH, Food Allergy Research and Education, the Food Allergy & Anaphylaxis Network, the Buckeye Foundation, and the Campaign Urging Research for Eosinophilic Diseases (CURED) Foundation. M. E. Rothenberg has received grants from the NIH, is a member of the steering committee for the International Eosinophil Society, has consultant arrangements with Immune Pharm, is an inventor of several relevant patents owned by Cincinnati Children's Hospital Medical Center, has received royalties from Teva for reslizumab, and has stock/stock options with and has received travel support from Immune Pharm. P. C. Fulkerson declares that she has no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 6
P. 1583-1585 - juin 2013 Retour au numéro
Article précédent
- Primary prevention of allergy by using protein hydrolysate: An achievable objective?
- S. Hasan Arshad
- Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism
- Amy P. Hsu, Kathryn J. Sowerwine, Monica G. Lawrence, Joie Davis, Carolyn J. Henderson, Kol A. Zarember, Mary Garofalo, John I. Gallin, Douglas B. Kuhns, Theo Heller, Joshua D. Milner, Jennifer M. Puck, Alexandra F. Freeman, Steven M. Holland
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?